Abstract
Brodalumab (Kyntheum (R)) is a human anti-interleukin-17 receptor A (IL-17RA) monoclonal antibody available for use in patients with moderate to sever......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
